Clinical summary

Print-friendly. CSV export

Patient: Anubis, 12-year-old neutered male Labrador. Diagnosis: T-cell lymphoma (PARR and flow cytometry confirmed, CD8+ peripheral T-cell), refractory to chemotherapy. Monitoring: owner-recorded observations extracted from a daily log, plus LiDAR 3D scans (Scaniverse). Tumor volume is an ellipsoid estimate from three axis measurements, method consistent throughout.

No tumor measurements yet. Post one like "tumor 70 x 50 x 38 mm" and this chart wakes up.

Latest known values

Appetite
normal2026-06-10
Defecation
normal2026-06-10
Immunophenotype
CD8+ peripheral T-cell2026-06-01
Meds given
asparaginase 16,000 U IM, benadryl 75 mg SQ2026-06-09
Mitotic count
94 per 2.37 mm²2026-05-15
Sleep
normal2026-06-10
Stage
IIIa2026-06-01
Tumor firmness
firm2026-06-10
Tumor size
lymph node still enlarged, little response to CCNU2026-06-09
Urination
normal2026-06-10
Weight
39.2 kg2026-06-09
Wound odor
mild2026-06-10

Tumor measurements

No measurements yet.

Treatment and clinical events

  • Tue, Jun 9, 2026: Chemo, Asparaginase 16,000 U IM (Little response to CCNU. Break week planned next, then vinblastine; radiation oncology consult being arranged.)
  • Tue, Jun 2, 2026: Chemo, Pivot to lomustine (CCNU) 70 mg (Protocol changed based on the sensitivity panel. Mupirocin added for the wound infection.)
  • Mon, Jun 1, 2026: Milestone, Drug sensitivity results: CHOP resistant (CD8+ peripheral T-cell lymphoma, stage IIIa. Asparaginase 0.60, mitoxantrone 0.59, lomustine 0.55; vincristine 0.15, doxorubicin 0.13.)
  • Tue, May 26, 2026: Chemo, Cyclophosphamide 225 mg (Partial mass reduction. Wound culture submitted; antibiotics switched to trimethoprim sulfa.)
  • Wed, May 20, 2026: Milestone, PARR: T-cell clonality confirmed (Monoclonal T-cell receptor gamma amplification; no B-cell amplification.)
  • Mon, May 18, 2026: Chemo, CHOP started: vincristine 0.68 mg IV (Sample submitted for flow cytometry and drug sensitivity testing.)
  • Fri, May 15, 2026: Milestone, Pathology: suspect lymphoma (Round cell tumor with aggressive features (mitotic count 94). Immunophenotyping recommended.)
  • Thu, May 14, 2026: Med change, Prednisone started, cyclosporine stopped (Allergy medication stopped; prednisone begun ahead of chemotherapy.)
  • Wed, May 13, 2026: Bloodwork, Cytology confirms neoplasia
  • Tue, May 12, 2026: Vet visit, Biopsy of the inguinal mass (Incisional biopsy collected from the ulcerated left inguinal mass, which had grown roughly fourfold despite antibiotics.)
  • Mon, Apr 27, 2026: Milestone, First sign: enlarged lymph node noticed (A swelling in the left inguinal area was first noticed at home. Early cytology read it as a reactive lymph node.)